Streetbeat News

Stock Prices

NSANY

TSLA

Julie and Chris Ramsey, known as 'Plug in Adventures,' completed a 17,000-mile journey from the North Pole to the South Pole in a modified Nissan Ariya electric SUV. This marks the first time a vehicle has made this trek, showcasing the potential of electric vehicles in extreme conditions. The Nissan Ariya, which competes with Tesla's Model Y, could gain marketing traction from this achievement. Tesla Inc. continues to lead the EV market with its Model Y becoming the top-selling vehicle worldwide and the start of Cybertruck deliveries.

Portfolio Pulse from Chris Katje

December 21, 2023 | 4:16 pm

DFS

Discover Financial Services' stock is trading higher following an upgrade from Citigroup, which changed its rating from Neutral to Buy and increased the price target from $93 to $133.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 4:14 pm

JNJ

MGTX

SNY

MeiraGTx Holdings plc (MGTX) announced an asset purchase agreement with Janssen Pharmaceuticals, a Johnson & Johnson (JNJ) company, for the gene therapy bota-vec for XLRP. MeiraGTx will receive $130 million in upfront and near-term milestone payments, with potential for an additional $285 million upon commercial sales and manufacturing technology transfer. J&J will handle any royalty or milestone payments to UCL Business plc. MeiraGTx also has a commercial supply agreement with J&J for bota-vec manufacturing. Previously, Sanofi SA (SNY) invested $30 million in MeiraGTx. The deals extend MeiraGTx's cash runway to mid-2026. MGTX shares surged 22.50% to $6.02.

Portfolio Pulse from Vandana Singh

December 21, 2023 | 4:11 pm

RCL

Royal Caribbean Cruises' stock (RCL) is trading higher following Tigress Financial's decision to maintain a Buy rating and increase the price target from $139 to $155.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 4:08 pm

ANNX

APLS

Annexon Inc (NASDAQ:ANNX) reported positive Phase 1 study results for ANX1502, showing dose-proportional pharmacokinetics and tolerability, with plans for a proof-of-concept study in 2024. The company also detailed a registrational program for ANX007 in geographic atrophy, including a Phase 3 trial and a head-to-head trial against Apellis Pharmaceuticals' Syfovre. Additionally, Annexon announced a public offering of shares and pre-funded warrants to raise $125 million. ANNX shares surged 26.10% to $3.63.

Portfolio Pulse from Vandana Singh

December 21, 2023 | 4:07 pm

PODD

Insulet Corporation's stock (PODD) is trading higher following an upgrade from Baird, changing its rating from Neutral to Outperform. Baird also increased the price target for Insulet from $180 to $238.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 4:05 pm

BA

FXI

Boeing is set to deliver a 787 Dreamliner to China's Juneyao Airlines on Thursday, marking the first direct delivery to a Chinese airline since 2019, according to flight data from FlightRadar 24 reported by Reuters.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 4:02 pm

GILD

HOOK

Gilead Sciences Inc (NASDAQ:GILD) has increased its stake in HOOKIPA Pharma Inc (NASDAQ:HOOK) by purchasing 15 million shares for approximately $21.25 million. This investment boosts Gilead's ownership to about 19.4% of HOOKIPA's outstanding shares. The deal also grants HOOKIPA the right to sell Gilead an additional $8.75 million in common stock in future equity raises. This agreement supersedes the one made in 2022. HOOKIPA is progressing with its HIV program, including the HB-500 vaccine, and Gilead has the option to take over development after Phase 1b trials. HOOKIPA's stock soared by 80.50%, while Gilead's shares saw a modest increase of 0.80%.

Portfolio Pulse from Vandana Singh

December 21, 2023 | 4:02 pm

JCI

Johnson Controls Intl (JCI) observed a significant volume of Feb 16 $60 call options traded at the ask price, with 2600 contracts at $1.0 compared to an open interest of 447. This activity comes ahead of their earnings report estimated to be released on January 31 before the market opens. The stock reference price at the time was $55.78.

Portfolio Pulse from Charles Gross

December 21, 2023 | 4:02 pm

BB

PAYX

WBD

ZJYL

Paychex, Inc. reported Q2 FY24 sales of $1.26 billion, missing estimates by $0.01 billion, but beat EPS estimates by $0.01. The stock fell 5.4%. Other stocks also declined: ZJYL after a Nasdaq compliance notice, BB following Q3 results, and others due to various reasons. WBD's CEOs discussed a potential merger.

Portfolio Pulse from Avi Kapoor

December 21, 2023 | 4:02 pm